GSE255685 provides per-sample processed expression-score files; values are not raw counts.
| Gene | Pathway | Expression (rlog) | vs Cohort | Cohort Median | %ile |
|---|---|---|---|---|---|
| APOE | Lipid Metabolism | 1.72 | bar=donor line=cohort median | 2.02 | 3.1% |
| FOXO3 | Insulin/IGF-1 Signaling | 10.30 | bar=donor line=cohort median | 9.99 | 91.2% |
| CETP | Lipid Metabolism | 4.95 | bar=donor line=cohort median | 5.05 | 38.5% |
| SIRT6 | Sirtuin Family | 8.16 | bar=donor line=cohort median | 8.34 | 14.2% |
| SIRT1 | Sirtuin Family | 8.67 | bar=donor line=cohort median | 8.72 | 45.0% |
| SIRT3 | Sirtuin Family | 7.65 | bar=donor line=cohort median | 7.49 | 77.2% |
| IGF1R | Insulin/IGF-1 Signaling | 10.45 | bar=donor line=cohort median | 10.21 | 76.9% |
| KLOTHO | Anti-aging | 2.35 | bar=donor line=cohort median | 2.51 | 25.6% |
| APOC3 | Lipid Metabolism | -2.11 | bar=donor line=cohort median | -2.11 | 58.2% |
| IL6 | Inflammation | 1.34 | bar=donor line=cohort median | 1.16 | 83.3% |
| TERT | Telomere Maintenance | 1.82 | bar=donor line=cohort median | 1.51 | 91.9% |
| IRS2 | Insulin/IGF-1 Signaling | 10.65 | bar=donor line=cohort median | 9.81 | 89.1% |
| TP53 | Tumor Suppression | 8.37 | bar=donor line=cohort median | 8.92 | 2.3% |
| SHC1 | Signal Transduction | 9.16 | bar=donor line=cohort median | 9.35 | 5.6% |
| ACE | Signal Transduction | 4.48 | bar=donor line=cohort median | 4.64 | 35.7% |
| # | Gene | ID | Type | Expression (Expression score) | Count |
|---|---|---|---|---|---|
| 1 | MT-RNR2 | 17.8 | 0 | ||
| 2 | B2M | 17.0 | 0 | ||
| 3 | EEF1A1 | 16.7 | 0 | ||
| 4 | MT-RNR1 | 16.3 | 0 | ||
| 5 | MT-CO1 | 16.3 | 0 | ||
| 6 | ACTB | 16.1 | 0 | ||
| 7 | HLA-C | 16.1 | 0 | ||
| 8 | TXNIP | 15.8 | 0 | ||
| 9 | MT-ND4 | 15.8 | 0 | ||
| 10 | HLA-E | 15.7 | 0 |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 1 | S100A8 | 14.2 | bar=donor line=cohort median | 14.2 | 14.2 | 51.1% | |
| 2 | S100A9 | 15.3 | bar=donor line=cohort median | 15.4 | 15.5 | 34.6% | |
| 3 | IL1B | 7.7 | bar=donor line=cohort median | 9.5 | 9.3 | 2.3% | |
| 4 | CXCL8 | 10.0 | bar=donor line=cohort median | 10.3 | 11.4 | 27.4% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 5 | MPO | 5.8 | bar=donor line=cohort median | 6.1 | 6.1 | 28.1% | |
| 6 | FCGR3B | 14.7 | bar=donor line=cohort median | 14.7 | 14.7 | 52.5% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 7 | LYZ | 14.4 | bar=donor line=cohort median | 14.4 | 14.3 | 52.5% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 8 | CD3D | 10.2 | bar=donor line=cohort median | 10.3 | 10.4 | 33.5% | |
| 9 | CD3E | 11.7 | bar=donor line=cohort median | 11.9 | 12.0 | 12.7% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 10 | MS4A1 | 11.2 | bar=donor line=cohort median | 10.9 | 10.9 | 77.2% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 11 | NKG7 | 11.2 | bar=donor line=cohort median | 11.5 | 11.7 | 12.4% | |
| 12 | GNLY | 12.1 | bar=donor line=cohort median | 12.0 | 12.1 | 44.6% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 16 | MT-CO1 | 16.3 | bar=donor line=cohort median | 16.4 | 16.4 | 21.0% | |
| 17 | MT-CO2 | 15.4 | bar=donor line=cohort median | 15.3 | 15.3 | 59.0% | |
| 18 | MT-ND1 | 15.5 | bar=donor line=cohort median | 15.2 | 15.2 | 83.0% |